Rotateq (Live Attenuated Pentavalent Rotavirus)

The rotavirus vaccine is essential for protecting young children from severe diarrhea caused by rotavirus infections. Here are some key points about this vaccine:

1. What is Rotavirus?
- Rotavirus is a highly contagious virus that primarily affects infants and young children.
- It spreads easily through fecal-oral transmission, contaminated surfaces, and close contact.
- Symptoms include severe watery diarrhea, vomiting, fever, and abdominal pain.

2. Rotavirus Vaccines in the United States:
- Two vaccines are currently licensed for infants in the United States:
- RotaTeq® (RV5): Given in 3 doses at ages 2 months, 4 months, and 6 months.
- Rotarix® (RV1): Given in 2 doses at ages 2 months and 4 months.
- The first dose of either vaccine should be administered before a child is 15 weeks of age.
- All doses of rotavirus vaccine should be given before the child turns 8 months old.
- Both vaccines are administered by putting drops in the child's mouth.

3. Effectiveness:
- Most children who receive the vaccine (about 9 out of 10) will be protected from severe rotavirus disease.
- Approximately 7 out of 10 children will be protected from rotavirus disease of any severity.

Remember to consult with your healthcare provider to ensure your child receives the recommended vaccinations.